Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
The report focuses on the Duchenne Muscular Dystrophy Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Duchenne Muscular Dystrophy Drug market.
Major Players in the Duchenne Muscular Dystrophy Drug market are:
Capricor Therapeutics
Marathon Pharmaceuticals
Sarepta Therapeutics
BioMarin Pharmaceutical
Akashi Therapeutics
Nippon Shinyaku
Bristol-Myers Squibb
Janssen Pharmaceuticals
Acceleron Pharma
Nobelpharma
Catabasis Pharmaceuticals
Santhera Pharmaceuticals
Asklepios BioPharmaceuticals
Eli Lilly
Summit Therapeutics
PTC Therapeutics
Pfizer
Lexicon Pharmaceuticals
On the basis of types, the Duchenne Muscular Dystrophy Drug market is primarily split into:
Steroid Therapy
Exon Skipping
Mutation Suppression
On the basis of applications, the market covers:
Translarna
Emflaza
EXONDYS 51
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Duchenne Muscular Dystrophy Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Duchenne Muscular Dystrophy Drug Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drug Market
1.2 Duchenne Muscular Dystrophy Drug Market Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Drug Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Duchenne Muscular Dystrophy Drug Market Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drug Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Duchenne Muscular Dystrophy Drug Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Duchenne Muscular Dystrophy Drug (2017-2029)
1.5.1 Global Duchenne Muscular Dystrophy Drug Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Duchenne Muscular Dystrophy Drug Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Duchenne Muscular Dystrophy Drug Industry
1.7 Impact of Carbon Neutrality on the Duchenne Muscular Dystrophy Drug Industry
2 Duchenne Muscular Dystrophy Drug Market Upstream and Downstream Analysis
2.1 Duchenne Muscular Dystrophy Drug Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Duchenne Muscular Dystrophy Drug Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Capricor Therapeutics
3.1.1 Capricor Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Marathon Pharmaceuticals
3.2.1 Marathon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Sarepta Therapeutics
3.3.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.3.4 Business Overview
3.4 BioMarin Pharmaceutical
3.4.1 BioMarin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Akashi Therapeutics
3.5.1 Akashi Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Nippon Shinyaku
3.6.1 Nippon Shinyaku Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Bristol-Myers Squibb
3.7.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Janssen Pharmaceuticals
3.8.1 Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Acceleron Pharma
3.9.1 Acceleron Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Nobelpharma
3.10.1 Nobelpharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Catabasis Pharmaceuticals
3.11.1 Catabasis Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Santhera Pharmaceuticals
3.12.1 Santhera Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Asklepios BioPharmaceuticals
3.13.1 Asklepios BioPharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Eli Lilly
3.14.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Summit Therapeutics
3.15.1 Summit Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.15.4 Business Overview
3.16 PTC Therapeutics
3.16.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Pfizer
3.17.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Lexicon Pharmaceuticals
3.18.1 Lexicon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Duchenne Muscular Dystrophy Drug Market Performance (2017-2022)
3.18.4 Business Overview
4 Global Duchenne Muscular Dystrophy Drug Market Landscape by Player
4.1 Global Duchenne Muscular Dystrophy Drug Sales and Share by Player (2017-2022)
4.2 Global Duchenne Muscular Dystrophy Drug Revenue and Market Share by Player (2017-2022)
4.3 Global Duchenne Muscular Dystrophy Drug Average Price by Player (2017-2022)
4.4 Global Duchenne Muscular Dystrophy Drug Gross Margin by Player (2017-2022)
4.5 Duchenne Muscular Dystrophy Drug Market Competitive Situation and Trends
4.5.1 Duchenne Muscular Dystrophy Drug Market Concentration Rate
4.5.2 Duchenne Muscular Dystrophy Drug Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Duchenne Muscular Dystrophy Drug Sales, Revenue, Price Trend by Type
5.1 Global Duchenne Muscular Dystrophy Drug Sales and Market Share by Type (2017-2022)
5.2 Global Duchenne Muscular Dystrophy Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Duchenne Muscular Dystrophy Drug Price by Type (2017-2022)
5.4 Global Duchenne Muscular Dystrophy Drug Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Duchenne Muscular Dystrophy Drug Sales, Revenue and Growth Rate of Steroid Therapy (2017-2022)
5.4.2 Global Duchenne Muscular Dystrophy Drug Sales, Revenue and Growth Rate of Exon Skipping (2017-2022)
5.4.3 Global Duchenne Muscular Dystrophy Drug Sales, Revenue and Growth Rate of Mutation Suppression (2017-2022)
6 Global Duchenne Muscular Dystrophy Drug Market Analysis by Application
6.1 Global Duchenne Muscular Dystrophy Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Duchenne Muscular Dystrophy Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate of Translarna (2017-2022)
6.3.2 Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate of Emflaza (2017-2022)
6.3.3 Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate of EXONDYS 51 (2017-2022)
7 Global Duchenne Muscular Dystrophy Drug Sales and Revenue Region Wise (2017-2022)
7.1 Global Duchenne Muscular Dystrophy Drug Sales and Market Share, Region Wise (2017-2022)
7.2 Global Duchenne Muscular Dystrophy Drug Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Duchenne Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Duchenne Muscular Dystrophy Drug Market Forecast (2022-2029)
8.1 Global Duchenne Muscular Dystrophy Drug Sales, Revenue Forecast (2022-2029)
8.1.1 Global Duchenne Muscular Dystrophy Drug Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Duchenne Muscular Dystrophy Drug Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Duchenne Muscular Dystrophy Drug Price and Trend Forecast (2022-2029)
8.2 Global Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.3 China Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.5 India Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Duchenne Muscular Dystrophy Drug Sales and Revenue Forecast (2022-2029)
8.3 Global Duchenne Muscular Dystrophy Drug Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Duchenne Muscular Dystrophy Drug Revenue and Growth Rate of Steroid Therapy (2022-2029)
8.3.2 Global Duchenne Muscular Dystrophy Drug Revenue and Growth Rate of Exon Skipping (2022-2029)
8.3.3 Global Duchenne Muscular Dystrophy Drug Revenue and Growth Rate of Mutation Suppression (2022-2029)
8.4 Global Duchenne Muscular Dystrophy Drug Consumption Forecast by Application (2022-2029)
8.4.1 Global Duchenne Muscular Dystrophy Drug Consumption Value and Growth Rate of Translarna (2022-2029)
8.4.2 Global Duchenne Muscular Dystrophy Drug Consumption Value and Growth Rate of Emflaza (2022-2029)
8.4.3 Global Duchenne Muscular Dystrophy Drug Consumption Value and Growth Rate of EXONDYS 51 (2022-2029)
8.5 Duchenne Muscular Dystrophy Drug Market Forecast Under COVID-19
9 Industry Outlook
9.1 Duchenne Muscular Dystrophy Drug Market Drivers Analysis
9.2 Duchenne Muscular Dystrophy Drug Market Restraints and Challenges
9.3 Duchenne Muscular Dystrophy Drug Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Duchenne Muscular Dystrophy Drug Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Duchenne Muscular Dystrophy Drug Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Drug Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Testosterone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period.
The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
Global Finasteride Tablets Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 96
The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profil......
Global Erectile Dysfunction Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 108
According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
Global Methyltestosterone Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 75
The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles......
Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Tamsulosin market:
According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Erectile Dysfunction Drug market:
According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Finasteride Tablets market:
According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
Finasteride Tablets - Global Market Insights and Sales Trends 2024
Published: 19-Dec-2023 Price: US 3350 Onwards Pages: 106
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 134
Report Overview:
The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period.
This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
